Eton Pharmaceuticals, Inc.
ETONDrug Manufacturers - Specialty & Generic
$52.18−2.78%As of Oct 30vs prior close
- Market cap
- $1.5B
- P/E (TTM)
- 111.0×
- P/E (FY1)
- 37.3×
- From 52W high
- −19.01%
- EPS (LTM)
- $0.47
- Revenue (LTM)
- $105.6M
- Net margin
- 12.02%
- Dividend yield
- 0.00%
Nomior Score
79
Vanguard CompounderSpeculativeTop 3% of the scored universe
Growth89
Quality69
Value43
Momentum98
Resilience39
Growth
+109.01%revenue a year over 6 fiscal years
YE19 $959KLTM $105.6M
Connections
Revenue to profitQ2 YE26
31% of revenue became net profit, up 44 pts on a year.
Who owns it
2funds, 1 tracked portfolio